Packing batteries with more punch
Indian researchers are working on cells that can store more energy, last longer
For the first time in a pandemic, Artificial Intelligence (AI) is playing a role like never before in areas ranging from diagnosing risk to doubt-clearing, from delivery of services to drug discovery in tackling the Covid-19 outbreak.
While BlueDoT, a Canadian health monitoring firm that crunches flight data and news reports using AI, is being credited by international reports to be the first to warn its clients of an impending outbreak on December 31, beating countries and international developmental agencies, the Indian tech space too is buzzing with coronavirus cracking activities.
CoRover, a start-up in the AI space that has earlier developed chatbots for railways ticketing platform, has now created a “video-bot” by collaborating with a doctor from Fortis Healthcare. In this platform, a real doctor from Fortis Healthcare — not a cartoon or an invisible knowledge bank — will take questions from people about Covid-19.
Apollo Hospitals has come up with a risk assessment scanner for Covid-19, which is available in six languages and guides people about the potential risk of having the virus. The Jaipur-based Sawai Man Singh Hospital is trying out a robot, made by robot maker Club First, to serve food and medicines to patients to lower the exposure of health workers to coronavirus patients.
“This is the first time in healthcare that Artificial Intelligence, Machine Learning, and Natural Language Processing are being used to create a Virtual Conversational AI platform, which assists anyone to be able to interact with doctors and have their queries answered unlike other search engines, which do not guarantee the authenticity of information,” CoRover’s Ankush Sabharwal claimed, while talking of its video-bot, which is likely to be launched soon.
Sabharwal told BusinessLine that answers to numerous questions have been recorded by Pratik Yashavant Patil, a doctor from Fortis Healthcare. In his AI avatar, Doctor Patil will bust myths, chat with you and will probably have answers to a lot of your questions.
Another start-up, Innoplexus AG, headquartered in Germany but founded by Indians, is claiming that its AI-enabled drug discovery platform is helping to arrive at combinations of existing drugs that may prove more efficacious in treating Covid-19 cases.
Its AI platform, after scanning the ‘entire universe of Covid-related data’ has thrown up results to show that Hydroxycholoroquine or Chroloquine, an anti-malaria drug that is being prescribed as a prophylactic for coronavirus under many protocols works more effectively with some other existing drugs than when it is used alone, the company claims.
“Our analysis shows that Chloroquine works more effectively in combination with Pegasys (a drug used to treat Hepatitis C] or Tocilizumab, (a rheumatoid arthritis drug) or Remdesivir (yet to be approved antiviral drug for Ebola) or Clarithromycin (an antibiotic). We are hoping to work with drug regulators and partners to test these in pre-clinical and clinical trials,” said Gunjan Bhardwaj, CEO, Innoplexus.
To be sure, hundreds of clinical trials are currently under way with several cocktails of medicines for Covid-19 across the world, and some of these drugs were part of trials held in China and Taiwan. The World Health Organization (WHO) itself is monitoring a global mega clinical trial for testing drugs for Covid-19 called ‘solidarity’, which India decided to join on Friday.
Indian researchers are working on cells that can store more energy, last longer
To fix a broken bone, doctors often harvest another bone from the patient’s body or from someone else. It ...
Superconductors from IIScScientists at IISc Bangalore have invented a device with a nanocrystal structure ...
Engineering and construction giant L&T has won a licence from the Council of Scientific & Industrial ...
Will a stock continue its current trend or will it reverse? We tell you how you can read chart patterns to ...
Sensex and Nifty 50 saw selling interest on Friday and slumped; selling pressure could continue
Investors with a long-term horizon can consider this offer
Most AMCs have been sending out cryptic e-mails. We tell you how to read between the lines
In these isolated times when people yearn for a slice of the familiar, amateur and professional chefs are ...
Forget the tuna. The island nation will keep you full and happy with coconut, koftas and jasmine
This year, on Facebook, I saw that someone had posted a list of EASY RESOLUTIONS. I didn’t copy them down but ...
With strokes of quirky humour, Partha Pratim Deb uses pulp, terracotta, glass and discarded cloth to create ...
Digital is becoming dominant media, but are companies and their ad agencies transforming fast enough to make a ...
Slow Network, promoted by journalist-lyricist Neelesh Misra, pushes rural products and experiences
How marketers can use the traditional exchange of festive wishes meaningfully
For Fortune, a brand celebrating its 20th anniversary, it was a rude shock to become the butt of social media ...
Three years after its inception, compliance with GST procedures remains a headache for exporters, job workers ...
Corporate social responsibility (CSR) initiatives of companies are altering the prospects for wooden toys of ...
Aequs Aerospace to create space for large-scale manufacture of toys at Koppal
And it has every reason to smile. Covid-19 has triggered a consumer shift towards branded products as ...
Please Email the Editor